Unbound MEDLINE

Might Adrenergic alpha(2C)-Agonists/alpha(2A)-Antagonists Become Novel Therapeutic Tools for Pain Treatment with Morphine? (1). Journal of medicinal chemistry [J Med Chem] Journal article

 
TitleMight Adrenergic alpha(2C)-Agonists/alpha(2A)-Antagonists Become Novel Therapeutic Tools for Pain Treatment with Morphine? (1).
Author(s)Cardinaletti C, Mattioli L, Ghelfi F, Del Bello F, Giannella M, Bruzzone A, Paris H, Perfumi M, Piergentili A, Quaglia W, Pigini M 
InstitutionDipartimento di Scienze Chimiche, Universita degli Studi di Camerino, Via S. Agostino 1, 62032 Camerino, Italy.
SourceJ Med Chem 2009 Nov 3.
AbstractThe imidazoline nucleus linked in position 2 via an oxyethylene bridge to a phenyl ring carrying an ortho substituent of moderate steric bulk provided alpha(2)-adrenergic (AR) ligands endowed with significant alpha(2C)-agonism/alpha(2A)-antagonism. Similar behavior was displayed by cirazoline (12). For their positive morphine analgesia modulation (due to alpha(2C)-AR stimulation) and sedation overcoming (due to alpha(2A)-AR antagonism), 8 and 11 might be useful as adjuvant agents in the management of pain with morphine.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19886609
  
Advertise on this site.